Fujifilm Cellular Dynamics Deal History & Licensing Activity
Fujifilm Cellular Dynamics is a life sciences. Over the past three years, Fujifilm Cellular Dynamics has been involved in 1 licensing and acquisition transaction, with a primary focus on Cell Therapy (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Cell Therapy
Focus Area
Ophthalmology
Fujifilm Cellular Dynamics Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Fujifilm Cellular Dynamics in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| OpCT-001 | Fujifilm | Cell Therapy | Phase 1 | collaboration | Jun 2025 |
Fujifilm Cellular Dynamics Pipeline Focus
Therapeutic areas and modalities where Fujifilm Cellular Dynamics is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Fujifilm Cellular Dynamics's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Ophthalmology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Ophthalmology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for ophthalmology
Cell Therapy Benchmarks
Upfront, milestone, and royalty benchmarks for cell therapy deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Fujifilm Cellular Dynamics Licensing & Deal Activity
Fujifilm Cellular Dynamics is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Fujifilm Cellular Dynamics ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Fujifilm Cellular Dynamics include Ophthalmology (2 deals and trials). In terms of modality, Fujifilm Cellular Dynamics has shown particular interest in cell therapy.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Fujifilm Cellular Dynamics and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Fujifilm Cellular Dynamics's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.